Follow
Patrick Hess
Patrick Hess
Principal Supervisor / Expert, European Central Bank
Verified email at ecb.int - Homepage
Title
Cited by
Cited by
Year
Impact of pharmacogenomics on the clinical laboratory
P Hess, D Cooper
Molecular Diagnosis 4 (4), 289-298, 1999
351999
Use of computationally derived protein structures of genetic polymorphisms in pharmacogenomics for drug design and clinical applications
K Ramnarayan, E Maggio, P Hess
US Patent App. 10/271,181, 2003
252003
China’s Financial System: Past Reforms, Future Ambitions and Current State
P Hess
Currency Cooperation in East Asia, 21-41, 2014
172014
Gene therapy: A brief review
P Hess
Clinics in laboratory medicine 16 (1), 197-211, 1996
111996
The ongoing evolution of payment instruments in China: A case study in financial innovation, and on the role of the central bank
P Hess
Cash in East Asia, 117-131, 2017
92017
Securities Clearing and Settlement in China: Markets, Infrastructures and Policy-Making
P Hess
ECB Occasional Paper Series, 1-31, 2010
82010
Reformen, Status und Perspektiven des chinesischen Finanzsystems
P Hess
Länderbericht China, 775-803, 2014
32014
CLAS 27TH NATIONAL MEETING SYLLABUS-Structural Pharmacogenomic Approach to the Evaluation of Drug Resistant Mutations in HIV-1 Protease
M Shenderovich, K Ramnarayan, R Kagan, P Hess
Journal of Clinical Ligand Assay 24 (2), 140-144, 2001
32001
Gene therapy monitoring: clinical monitoring for efficacy and potential toxicity
P Hess, GJ Dougherty
Molecular Diagnosis 2 (2), 147-155, 1997
31997
China’s monetary policy: Institutional setting, tools and challenges
P Hess
Monetary Policy Implementation in East Asia, 13-30, 2020
22020
Demand and Supply of Shadow Banking in China
X Zhang, P Hess
Central Banking and Financial Stability in East Asia, 141-156, 2015
12015
Use of computationally derived protein structures of genetic polymorphisms in pharmacogenomics for drug design and clinical applications
K Ramnarayan, E Maggio, P Hess
US Patent App. 11/229,393, 2006
12006
The supervision and regulation of climate risks for banks: overview from the perspective of a European practitioner
P Hess
Green Finance 4 (3), 295-309, 2022
2022
The editorial staff wishes to express its gratitude to the following individuals for their excellent critical reviews for Molecular Diagnosis these past two years: Maria E …
H Aviv, A Bagg, D Baldwin, WP Bennett, JA Biegel, R Braziel, MP Busch, ...
Molecular Diagnosis 6 (4), 2001
2001
The editorial staff wishes to express its gratitude to the individuals below for their excellent critical reviews for Molecular Diagnosis these past two years.
A Anguiano, DA Arber, D Asman, A Bagg, RR Barathur, S Barthold, ...
Molecular Diagnosis 4 (4), 1999
1999
The editorial staff wishes to express its gratitude to the individuals listed below who served as guest re-viewers during the past year. Douglas Anthony, MD, PhD Robert Bowser, PhD
R Braziel, D Coppola, AC Hassett, D Crisan, GJ Dougherty, R Deka, ...
Molecular Diagnosis 2 (4), 1997
1997
Un approccio di farmacogenetica strutturale alla valutazione delle mutazioni di farmaco-resistenza nella proteasi di HIV-1
M Shenderovich, K Ramnarayan, R Kagan, P Hess
CLINICAL LIGAND ASSAY, 143, 0
The system can't perform the operation now. Try again later.
Articles 1–17